Oaktree Acquisition Corp. III Life Sciences (OACC) Retained Earnings (2024 - 2026)

Oaktree Acquisition Corp. III Life Sciences has reported Retained Earnings for 3 years, with the latest figure at -$7.2 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 10.85% year-over-year to -$7.2 million; the trailing twelve-month figure through Mar 2026 stood at -$7.2 million (down 10.85% YoY), and the FY2025 full-year result was -$6.8 million, down 11.45% from the prior year.
• Retained Earnings for Q1 2026 stood at -$7.2 million, down from -$6.8 million in the prior quarter.
• The five-year high for Retained Earnings was -$6.1 million in Q4 2024, with the low at -$7.2 million in Q1 2026.
• Historically, Retained Earnings has averaged -$6.6 million across 3 years, with a median of -$6.7 million in 2025.
• Annual changes were most pronounced in 2025 — Retained Earnings declined 11.45% — and 2026, when it dropped 10.85%.
• Oaktree Acquisition Corp. III Life Sciences' Retained Earnings stood at -$6.1 million in 2024, then fell by 11.45% to -$6.8 million in 2025, then decreased by 6.74% to -$7.2 million in 2026.
• The last three Retained Earnings figures came in at -$7.2 million (Q1 2026), -$6.8 million (Q4 2025), and -$6.8 million (Q3 2025), per Business Quant data.